ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C03CA01 | G | Furosemide - 40mg | 1664 | 24878/80 | DIURESAL | 40mg | 24 | Tablet, scored | Oral | Mediterranean Pharmaceutical Company | Pharmaceuticals Lagap SA | Switzerland | 118,258 L.L | 23.08 | A1 | Lagap SA | Switzerland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C03CA01 | B | Furosemide - 40mg | 10878 | 28122/1 | LASIX | 40mg | 20 | Tablet | Oral | Mersaco | Opella Healthcare International SAS | France | 120,946 L.L | 23.08 | A1 | Sanofi Aventis Deutschland GmbH | Germany | 2/5/2024 | 0 |
C03CA01 | G | Furosemide - 40mg | 988 | MP MO 581/91 | APO-FUROSEMIDE | 40mg | 100 | Tablet, scored | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 862,747 L.L | 23.08 | A2 | Apotex Inc | Canada | 2/5/2024 | 0 |
C03CA01 | G | Furosemide - 40mg | 11501 | 113621/1 | BIOLASOMIDE | 40mg | 50 | Tablet | Oral | BroadMed SAL | Biofarma Ilac San. ve Tic. AS | Turkey | 181,419 L.L | 23.08 | A1 | Biofarma Ilac San. ve Tic. AS | Turkey | 2/5/2024 | 0 |
C03CA01 | G | Furosemide - 40mg | 10791 | 89221/1 | FURESIX 40 | 40mg | 30 | Tablet | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 166,381 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
C03CA01 | G | Furosemide - 40mg | 4738 | 27515/93 | FUROSETIC | 40mg | 30 | Tablet, scored | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 121,586 L.L | 23.08 | A1 | 2/5/2024 | 0 |